Summary
GABA was injected intraperitoneally to rats in single doses of 2.5 to 1500 mg/kg. Thirty minutes after injection a dose-dependent increase in dopamine (DA) and a decrease in noradrenaline (NA) content were observed in the brain. However, in the lowest dose range these levels showed small but significant changes in the opposite direction. The accumulation of dopa after inhibition of the aromatic L-aminoacid decarboxylase was enhanced by i.p. GABA both in DA- and in NA-predominated brain regions, the dose-response relations being complex. Increased levels of serotonin (5-HT), 5-hydroxyindole-acetic acid (5-HIAA) and tryptophan as well as enhanced accumulation of 5-hydroxytryptophan, induced by decarboxylase inhibition were also observed.
The general pattern of effects was similar to that previously observed after intracerebroventricular injection of GABA, although the intraperitoneal doses required were higher. It is suggested that a certain penetration of GABA from the blood into the brain can occur, leading to changes in the physiological activity of monoaminergic neurons.
Similar content being viewed by others
References
Andén, N.-E., Stock, G.: Inhibitory effect of gammahydroxybutyric acid and gammaaminobutyric acid on the dopamine cells in the substantia nigra. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 89–92 (1973)
Atack, C. V.: The determination of dopamine by a modification of the dihydroxyindole fluorimetric assay. Br. J. Pharmacol. 48, 699–714 (1973)
Atack, C., Lindqvist, M.: Conjoint native and orthophthaldialdehyde condensate assay for the fluorimetric determination of 5-hydroxyindole in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 279, 267–284 (1973)
Atack, C. V., Magnusson, T.: Individual elution of noradrenaline (together with adrenaline), dopamine, 5-hydroxytryptamine and histamine from a single strong cation exchange column, by means of mineral acidorganic solvent mixtures. J. Pharm. Pharmacol. 22, 625–627 (1970)
Bédard, P., Carlsson, A., Lindqvist, M.: Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 272, 1–15 (1972)
Bertler, Å., Carlsson, A., Rosengren, E.: A method for the fluorimetric determination of adrenaline and noradrenaline in tissues. Acta Physiol. Scand. 44, 273–292 (1958)
Biswas, B., Carlsson, A.: The effect of intracerebroventricularly administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 41–46 (1977a)
Biswas, B., Carlsson, A.: Effect of intraperitoneally administered GABA on the locomotor activity of mice. Psychopharmacology, in press (1977b)
Carlsson, A.: Dopaminergic auto-receptors. In: Chemical Tools in Catecholamine Research II. Almgren, O., Carlsson, A., Engel, J. (eds.), pp. 219–225. Amsterdam: North Holland Publishing Company 1975
Carlsson, A., Lindqvist, M.: Effect of ethanol on the hydroxylation of tyrosine and tryptophan in rat brain in vivo. J. Pharm. Pharmacol. 25, 437–440 (1973)
Carlsson, A., Davis, J. N., Kehr, W., Lindqvist, M., Atack, C. V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedeberg's Arch. Pharmacol. 275, 153–168 (1972)
Fuxe, K., Agnati, L. F., Hökfelt, T., Jonsson, G., Lidbrink, P., Ljungdahl, Å.: The effect of dopamine receptor stimulating and blocking agents on the activity of suppressive dopamine receptors and on the amine turnover in various dopamine nerve terminal systems in the rat brain. J. Pharmacol. 6, 117–129 (1975)
Gessa, G. L., Vargiu, L., Crabai, F., Boero, G. C., Cagoni, F., Camba, R.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci 5, 1921–1930 (1966)
Hawkins, J. E., Sarett, L. H.: On the efficacy of aspargine, glutamine, γ-aminobutyric acid and 2-pyrrolidinone in preventing chemically induced seizures in mice. Clin. Chim. Acta 2, 48 (1957)
Kehr, W., Carlsson, A., Lindqvist, M.: A method for the determination of 3,4-dihydroxyphenylalanine (DOPA) in brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 274, 273–280 (1972)
Kehr, W., Lindqvist, M., Carlsson, A.: Distribution of dopamine in the rat cerebral cortex. J. Neural Transm. 38, 173–180 (1976)
Kuriyama, K., Sze, P. Y.: Blood brain barrier to H3-γ-aminobutyric acid in normal and aminooxyacetic acid treated animals. Neuropharmacology 10, 103–108 (1971)
Tower, D. B.: The administration of gammaaminobutyric acid to man: systemic effects and anticonvulsant action. In: Inhibition in the Nervous System and Gammaaminobutyric Acid (Roberts, E., Baxter, C. F., Harreveld, A. V., Wiersmar, C. A. G., Adey, W. R., Killam, K. F. (eds.), pp. 562–577. New York: Pergamon Press 1960
Waalkes, T. P., Udenfriend, S.: A fluorimetric method for the estimation of tyrosine in plasma and tissues. J. Lab. Clin. Med. 50, 733–736 (1957)
Wachtel, H., Andén, N.-E.: The motor activity of rats following intracerebral injections of drugs influencing GABA mechanisms. To be published (1977)
Yessaian, N. H., Armenian, A. R., Buniatian, H. Ch.: Effect of γ-aminobutyric acid on brain serotonin and catecholamines. J. Neurochem. 16, 1425–1433 (1969)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Biswas, B., Carlsson, A. The effect of intraperitoneally administered GABA on brain monoamine metabolism. Naunyn-Schmiedeberg's Arch. Pharmacol. 299, 47–51 (1977). https://doi.org/10.1007/BF00508636
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00508636